Literature DB >> 13192187

The use of hemolysin inhibition in the study of experimental and clinical hyperlipemia; the non-specific inhibition of streptolysin O, by serum lipoproteins.

G H STOLLERMAN.   

Abstract

Entities:  

Keywords:  CHOLESTEROL/in blood; SAPONINS; STREPTOLYSIN/antagonists

Mesh：

Substances：

Year:  1954        PMID： 13192187      PMCID： PMC1072536          DOI： 10.1172/JCI102998

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

1.  The Role of Heparin in Lipoprotein Metabolism.

Authors:  C B Anfinsen; E Boyle; R K Brown
Journal:  Science       Date:  1952-05-30       Impact factor: 47.728

2.  The relationship of streptolysin S inhibitor to phospholipids in the serum of human beings and experimental animals.

Authors:  G H STOLLERMAN; B B BRODIE; J M STEELE
Journal:  J Clin Invest       Date:  1952-02       Impact factor: 14.808

3.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

4.  The association of lipoproteins with the inhibition of streptolysin S by serum.

Authors:  G H STOLLERMAN; A W BERNHEIMER; C M MacLEOD
Journal:  J Clin Invest       Date:  1950-12       Impact factor: 14.808

5.  Inhibition of streptolysin S by the serum of patients with rheumatic fever and acute streptococcal pharyngitis.

Authors:  G H STOLLERMAN; A W BERNHEIMER
Journal:  J Clin Invest       Date:  1950-09       Impact factor: 14.808

6.  Non-specific antistreptolysin reactions in hepatitis sera; antistreptolysin titers before and after removal of lipids from the hepatitis sera with bentonite.

Authors:  N OKER-BLOM; E NIKKILA; T KALAJA
Journal:  Ann Med Exp Biol Fenn       Date:  1950

7.  Antistreptolysin O and antihyaluronidase titers in health and in various diseases.

Authors:  L A RANTZ; J M DI CAPRIO; E RANDALL
Journal:  Am J Med Sci       Date:  1952-08       Impact factor: 2.378

8.  Antistreptolysin "O" in urine and serum of patients with the nephrotic syndrome.

Authors:  D A RYTAND; L A RANTZ; E RANDALL
Journal:  J Clin Invest       Date:  1950-06       Impact factor: 14.808

9.  The nature of antistreptolysin S in the sera of man and of other species; the lipoprotein properties of antistreptolysin S.

Authors:  J H HUMPHREY
Journal:  Br J Exp Pathol       Date:  1949-10

10.  Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.

Authors:  D B ZILVERSMIT; A K DAVIS
Journal:  J Lab Clin Med       Date:  1950-01
View more
  5 in total

1.  [Significance of serum lipids for antistreptolysin titer. I].

Authors:  F SCHEIFFARTH; G BERG; F LEGLER; G PETERSMANN
Journal:  Klin Wochenschr       Date:  1957-04-15

2.  Some factors influencing the effect of cholesterol on streptolysin O activity.

Authors:  K C Watson; T P Rose; E J Kerr
Journal:  J Clin Pathol       Date:  1972-10       Impact factor: 3.411

3.  Polyene antibiotics in assessing significance of antistreptolysin O activity.

Authors:  K C Watson; E J Kerr
Journal:  J Clin Pathol       Date:  1978-03       Impact factor: 3.411

4.  [Results of various methods of separation of specific and unspecific antistreptolysin O titer in human serum].

Authors:  J Knolle
Journal:  Klin Wochenschr       Date:  1966-08-01

5.  The haemolysins of normal and malignant rat tissues.

Authors:  R W BALDWIN
Journal:  Br J Cancer       Date:  1957-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.